FindTrial
Sign In

Effect of Telenursing on the Sexuality of women with Breast Cancer

Telenursing in the Sexual Function of women with Breast Cancer: clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-1056fgjk
Enrollment
Unknown
Registered
2021-11-08
Start date
2022-02-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sexuality

Interventions

Experimental group: 55 women with breast cancer undergoing curative treatment will receive 4 sexual counseling over the phone, with intervals of 15 days, lasting approximately 40 to 60 minutes. And, 5
H02.403.840

Sponsors

Universidade Federal do Ceará
Lead Sponsor
Universidade Federal do Ceará
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Women with breast cancer in stages I-IV; Being on cancer treatment (chemotherapy, radiotherapy or hormone therapy) for at least six months, as a survey showed that the majority (66%) of patients develop sexual problems during the treatment of breast cancer and not after (22%) (HUMMEL et al, 2017); Have at least one telephone contact to receive the intervention; Having a partner.

Exclusion criteria

Exclusion criteria: Treatment of another type of cancer; Having hearing impairment, as it makes communication via telephone impossible, which will be assessed through the Whisper Test (LABANCA et al, 2017); Participate in any intervention for the treatment of sexual dysfunction or climacteric, since the comparison between the control group and the intervention group occurs in the best way when there are no co-interventions (drugs, therapies or behaviors) that alter the risk of developing / altering the outcome of interest (HULLEY et al, 2015); Women with mental restrictions, confirmed by medical diagnosis, which makes it impossible to understand the instruments.

Design outcomes

Primary

MeasureTime frame
Assess sexual function, verified by the experimental method of the randomized clinical trial type. Sexual function will be measured using the Female Sexual Function Index (FSFI), which has scores ranging from 2 to 36, being classified as 2 to 26.55 women with sexual dysfunction and above 26.55 women without sexual dysfunction—

Secondary

MeasureTime frame
Secondary outcomes are not expected—

Countries

Brazil

Contacts

Public ContactIarlla Ferreira

Universidade Federal do Ceará

iarlla@live.com+55-085-33668451

Outcome results

None listed

Source: REBEC (via WHO ICTRP)